Colorectal cancer (CRC) represents the second leading cause of cancer-related deaths
worldwide. The pathogenesis of CRC is a complex multistep process. Among other factors …

The gut microbiota plays a critical role in the modulation of host metabolism and immune
response, and its impairment has been implicated in many gastrointestinal and …

Despite substantial progress in cancer microbiome research, recognized confounders and
advances in absolute microbiome quantification remain underused; this raises concerns …

Gut microbiota is involved in intricate and active metabolic processes the host's brain
function, especially its role in immune responses, secondary metabolism, and symbiotic …

Simple Summary Inflammatory Bowel Diseases (IBDs) are increasingly prevalent
pathologies due to the rise in incidence in some geographic areas and the improvement in …

Background Colorectal cancer (CRC) poses a global health threat, with the oral microbiome
increasingly implicated in its pathogenesis. This study leverages Mendelian Randomization …

The intricate interplay between the gut microbiome and colorectal cancer (CRC) presents
novel avenues for early diagnosis and prognosis, crucial for improving patient outcomes …

Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC)
and comprises a chronic gastrointestinal tract disorder characterized by hyperactive and …

The gut microbiota has been recognized as an important determinant in the initiation and
progression of colorectal cancer (CRC), with recent studies shining light on the molecular …

Photodynamic therapy (PDT) is a minimally invasive treatment that effectively targets cancer
and inflammatory diseases. It has gained recognition for its efficacy, low toxicity, and …